Adjuvant Therapy is Associated with Improved Survival After Curative Resection for Hilar Cholangiocarcinoma: A Multi-Institution Analysis from the U.S. Extrahepatic Biliary Malignancy Consortium

BACKGROUND: Curative-intent treatment for localized hilar cholangiocarcinoma (HC) requires surgical resection. However, the effect of adjuvant therapy (AT) on survival is unclear. We analyzed the impact of AT on overall (OS) and recurrence free survival (RFS) in patients undergoing curative resectio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Surg Oncol
Main Authors: Krasnick, Bradley A., Jin, Linda X., Davidson, Jesse T., Sanford, Dominic E., Ethun, Cecilia G., Pawlik, Timothy M., Poultsides, George A., Tran, Thuy, Idrees, Kamran, Hawkins, William G., Chapman, William C., Majella Doyle, Maria B., Weber, Sharon M., Strasberg, Steven M., Salem, Ahmed, Martin, Robert C.G., Isom, Chelsea A., Scoggins, Charles, Schmidt, Carl R., Shen, Perry, Beal, Eliza, Hatzaras, Ioannis, Shenoy, Rivfka, Maithel, Shishir Kumar, Fields, Ryan C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5924689/
https://ncbi.nlm.nih.gov/pubmed/29284072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jso.24836
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados